X-ray crystal structure of the ancestral 3-ketosteroid receptor- progesterone-mifepristone complex shows mifepristone bound at the coactivator binding interface

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Colucci, Jennifer K ^a   Ortlund, Eric A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SEQUENCE; BINDING SITES; CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; HUMANS; MIFEPRISTONE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MULTIPROTEIN COMPLEXES; PROGESTERONE; PROTEIN BINDING; PROTEIN CONFORMATION; RECEPTORS, STEROID; SEQUENCE ALIGNMENT;

EID: 84894130933     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080761     Document Type: Article

References (37)

1. Bridgham JT, Eick GN, Larroux C, Deshpande K, Harms MJ et al. (2010) Protein evolution by molecular tinkering: diversification of the nuclear receptor superfamily from a ligand-dependent ancestor. PLOS Biol 8. PubMed: 20957188.
2. Nagy L, Schwabe JW (2004) Mechanism of the nuclear receptor molecular switch. Trends Biochem Sci 29: 317-324. doi:10.1016/j.tibs.2004.04.006. PubMed: 15276186. (Pubitemid 38968764)
3. O'Malley BW, Tsai MJ (1992) Molecular pathways of steroid receptor action. Biol Reprod 46: 163-167. doi:10.1095/biolreprod46.2.163. PubMed: 1536890.
4. McKenna NJ, O'Malley BW (2002) Minireview: nuclear receptor coactivators-an update. Endocrinology 143: 2461-2465. doi:10.1210/en.143.7.2461. PubMed: 12072374. (Pubitemid 34701305)
5. McKenna NJ, O'Malley BW (2002) Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108: 465-474. doi:10.1016/S0092- 8674(02)00641-4. PubMed: 11909518. (Pubitemid 34260872)
6. Nakao R, Haji M, Yanase T, Ogo A, Takayanagi R et al. (1992) A single amino acid substitution (Met786-Val) in the steroid-binding domain of human androgen receptor leads to complete androgen insensitivity syndrome. J Clin Endocrinol Metab 74: 1152-1157. doi:10.1210/jc.74.5.1152. PubMed: 1569163.
7. Imasaki K, Hasegawa T, Okabe T, Sakai Y, Haji M et al. (1994) Single amino acid substitution (840Arg-His) in the hormone-binding domain of the androgen receptor leads to incomplete androgen insensitivity syndrome associated with a thermolabile androgen receptor. Eur J Endocrinol 130: 569-574. doi:10.1530/eje.0.1300569. PubMed: 8205256. (Pubitemid 24203410)
8. Quigley CA, De Bellis A, Marschke KB, el-Awady MK, Wilson EM et al. (1995) Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev 16: 271-321. doi:10.1210/edrv-16-3-271. PubMed: 7671849.
9. Nagpal S, Saunders M, Kastner P, Durand B, Nakshatri H et al. (1992) Promoter context- and response element-dependent specificity of the transcriptional activation and modulating functions of retinoic acid receptors. Cell 70: 1007-1019. doi:10.1016/0092-8674(92)90250-G. PubMed: 1326406.
10. Rodriguez AL, Tamrazi A, Collins ML, Katzenellenbogen JA (2004) Design, synthesis, and in vitro biological evaluation of small molecule inhibitors of estrogen receptor alpha coactivator binding. J Med Chem 47: 600-611. doi:10.1021/jm030404c. PubMed: 14736241. (Pubitemid 38129718)
11. Harms MJ, Eick GN, Goswami D, Colucci JK, Griffin PR et al. (2013) Biophysical mechanisms for large-effect mutations in the evolution of steroid hormone receptors. Proc Natl Acad Sci U S A. PubMed: 23798447
12. Bridgham JT, Ortlund EA, Thornton JW (2009) An epistatic ratchet constrains the direction of glucocorticoid receptor evolution. Nature 461: 515-519. doi:10.1038/nature08249. PubMed: 19779450.
13. Ortlund EA, Bridgham JT, Redinbo MR, Thornton JW (2007) Crystal structure of an ancient protein: evolution by conformational epistasis. Science 317: 1544-1548. doi:10.1126/science.1142819. PubMed: 17702911. (Pubitemid 47417432)
14. Thornton JW (2004) Resurrecting ancient genes: experimental analysis of extinct molecules. Nat Rev Genet 5: 366-375. doi:10.1038/nrg1324. PubMed: 15143319.
15. Harms MJ, Thornton JW (2010) Analyzing protein structure and function using ancestral gene reconstruction. Curr Opin Struct Biol 20: 360-366. doi:10.1016/j.sbi.2010.03.005. PubMed: 20413295.
16. Kohn JA, Deshpande K, Ortlund EA (2012) Deciphering modern glucocorticoid cross-pharmacology using ancestral corticosteroid receptors. J Biol Chem 287: 16267-16275. doi:10.1074/jbc.M112.346411. PubMed: 22437833.
17. Eick GN, Colucci JK, Harms MJ, Ortlund EA, Thornton JW (2012) Evolution of minimal specificity and promiscuity in steroid hormone receptors. PLoS Genet 8: e1003072. PubMed: 23166518.
18. Otwinowski Z, Minor W (1997) Processing of X-ray diffraction data collected in oscillation mode. Macromolecular Crystallography, Pt A 276: 307-326. doi:10.1016/S0076-6879(97)76066-X. (Pubitemid 27085611)
19. Pereira de Jesus-Tran K, Cote PL, Cantin L, Blanchet J, Labrie F et al. (2006) Comparison of crystal structures of human androgen receptor ligand-binding domain complexed with various agonists reveals molecular determinants responsible for binding affinity. Protein Sci 15: 987-999. doi:10.1110/ps.051905906. PubMed: 16641486.
20. Adams PD, Afonine PV, Bunkóczi G, Chen VB, Davis IW et al. (2010) PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66: 213-221. doi:10.1107/ S0907444909052925. PubMed: 20124702.
21. Chen VB, Arendall WB 3rd, Headd JJ, Keedy DA, Immormino RM et al. (2010) MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr 66: 12-21. doi:10.1107/S1744309109042018. PubMed: 20057044.
22. Davis IW, Leaver-Fay A, Chen VB, Block JN, Kapral GJ et al. (2007) MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res 35: W375-W383. doi:10.1093/nar/gkm216. PubMed: 17452350.
23. Heikinheimo O, Kekkonen R, Lähteenmäki P (2003) The pharmacokinetics of mifepristone in humans reveal insights into differential mechanisms of antiprogestin action. Contraception 68: 421-426. doi:10.1016/S0010-7824(03)00077-5. PubMed: 14698071. (Pubitemid 38112740)
24. Song LN, Coghlan M, Gelmann EP (2004) Antiandrogen effects of mifepristone on coactivator and corepressor interactions with the androgen receptor. Mol Endocrinol 18: 70-85. PubMed: 14593076. (Pubitemid 38073155)
25. Nieman LK, Chrousos GP, Kellner C, Spitz IM, Nisula BC et al. (1985) Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486. J Clin Endocrinol Metab 61: 536-540. doi:10.1210/jcem-61-3-536. PubMed: 2991327. (Pubitemid 15243969)
26. Hodgson MC, Astapova I, Cheng S, Lee LJ, Verhoeven MC et al. (2005) The androgen receptor recruits nuclear receptor CoRepressor (N-CoR) in the presence of mifepristone via its N and C termini revealing a novel molecular mechanism for androgen receptor antagonists. J Biol Chem 280: 6511-6519. doi:10.1074/jbc.M408972200. PubMed: 15598662. (Pubitemid 40341200)
27. Cadepond F, Ulmann A, Baulieu EE (1997) RU486 (mifepristone): mechanisms of action and clinical uses. Annu Rev Med 48: 129-156. doi:10.1146/annurev.med. 48.1.129. PubMed: 9046951. (Pubitemid 27101820)
28. Zhang S, Jonklaas J, Danielsen M (2007) The glucocorticoid agonist activities of mifepristone (RU486) and progesterone are dependent on glucocorticoid receptor levels but not on EC50 values. Steroids 72: 600-608. doi:10.1016/j.steroids.2007.03.012. PubMed: 17509631. (Pubitemid 46764797)
29. Boehm MF, McClurg MR, Pathirana C, Mangelsdorf D, White SK et al. (1994) Synthesis of high specific activity [3H]-9-cis-retinoic acid and its application for identifying retinoids with unusual binding properties. J Med Chem 37: 408-414. doi:10.1021/jm00029a013. PubMed: 8308867. (Pubitemid 24079951)
30. Krissinel E, Henrick K (2007) Inference of macromolecular assemblies from crystalline state. J Mol Biol 372: 774-797. doi:10.1016/j.jmb.2007.05.022. PubMed: 17681537. (Pubitemid 47321791)
31. Williams SP, Sigler PB (1998) Atomic structure of progesterone complexed with its receptor. Nature 393: 392-396. doi:10.1038/30775. PubMed: 9620806. (Pubitemid 28269716)
32. Carroll SM, Ortlund EA, Thornton JW (2011) Mechanisms for the evolution of a derived function in the ancestral glucocorticoid receptor. PLoS Genet 7: e1002117. PubMed: 21698144.
33. Bledsoe RK, Madauss KP, Holt JA, Apolito CJ, Lambert MH et al. (2005) A ligand-mediated hydrogen bond network required for the activation of the mineralocorticoid receptor. J Biol Chem 280: 31283-31293. doi:10.1074/jbc. M504098200. PubMed: 15967794. (Pubitemid 41291866)
34. Pratt WB, Toft DO (1997) Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr Rev 18: 306-360. doi:10.1210/er.18.3.306. PubMed: 9183567. (Pubitemid 27246880)
35. Watkins RE, Wisely GB, Moore LB, Collins JL, Lambert MH et al. (2001) The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity. Science 292: 2329-2333. doi:10.1126/science.1060762. PubMed: 11408620. (Pubitemid 32568055)
36. Patch JA, Barron AE (2003) Helical peptoid mimics of magainin-2 amide. J Am Chem Soc 125: 12092-12093. doi:10.1021/ja037320d. PubMed: 14518985. (Pubitemid 37238834)
37. Wang Y, Chirgadze NY, Briggs SL, Khan S, Jensen EV et al. (2006) A second binding site for hydroxytamoxifen within the coactivator-binding groove of estrogen receptor beta. Proc Natl Acad Sci U S A 103: 9908-9911. doi:10.1073/pnas.0510596103. PubMed: 16782818. (Pubitemid 43993596)